These programs are intended for geriatricians, infectious disease specialists, and primary care providers who care for high-risk patients.

Aims

• The aim is to enhance their ability to identify, diagnose, and manage COVID-19 effectively, particularly in populations with limited disease awareness and hesitancy toward oral treatment. It is important to emphasize that COVID-19 remains a significant disease, with high rates of hospitalization and mortality among high-risk groups.

Funding Information

• Projects covering multiple countries requesting up to $175,000 will be considered.
• Projects costing higher than this may be considered on a case-by-case basis.
• Maximum project length is one year

Project Types and Area of Interest

• Through this RFP it is their intent to support educational programs for HCPs that address knowledge gaps in identifying patients at high risk for developing severe COVID-19 outcomes, including hospitalization or death, and are designed to help achieve the following goals:
  • Improve identification of patients with high-risk conditions and their eligibility for COVID-19 treatment.
  • Recognize the importance of early COVID-19 intervention/treatment in high-risk patients.
  • Outline COVID-19 complications associated with high-risk conditions and impact they have on patients and healthcare systems.
  • Long term impact of COVID-19, including long COVID and worsening or new onset of diseases (diabetes, Cardiovascular diseases).
• Projects that use web based platforms and tools for educating HCPs in multiple countries will be considered. And thus platforms should support multiple languages/translations for HCPs from multiple countries.

Target Audiences

• Infectious Disease Specialists
• Primary Care Providers, including but not limited to, Geriatricians, Family Medicine, Internal Medicine, and Urgent Care Providers.

Geographic Scope

• Global (ex-US) with priority in Europe, Asia-Pacific region.

Eligibility Criteria

• The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
• Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
• If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.
• applicant must be the project/program lead or an authorized designee of such individual (e.g., project/program lead’s grant coordinator).
• The project/program lead must be an employee or contractor of the requesting organization.
• Requesting organization must be legally able to receive award funding directly from Pfizer Inc. They strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.
• For projects offering continuing education credit, the requesting organization must be accredited.

For more information, visit Pfizer.

https://cdn.pfizer.com/pfizercom/2025-07/2025-VAC-G-COVID-19BurdenonHighRiskPopulation-KG.pdf?VersionId=IoHj8Flw.f.tH.p4nIM10lobtoh5s0ig